Dravet syndrome - considerable delay in making the diagnosis

被引:21
作者
Bremer, A. [1 ]
Lossius, M. I. [1 ]
Nakken, K. O. [1 ]
机构
[1] Oslo Univ Hosp, Natl Ctr Epilepsy, Div Surg & Neurosci, Oslo, Norway
来源
ACTA NEUROLOGICA SCANDINAVICA | 2012年 / 125卷 / 05期
关键词
adults; children; delayed diagnosis; Dravet syndrome; epilepsy; genetics; treatment; SEVERE MYOCLONIC EPILEPSY; CHANNEL GENE SCN1A; DE-NOVO MUTATIONS; INFANCY;
D O I
10.1111/j.1600-0404.2011.01609.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives To assess delay in diagnosis and clinical characteristics of Dravet syndrome based on the Dravet register at The National Centre for Epilepsy in Norway. Material and methods - Medical records of patients diagnosed with Dravet syndrome since 2007 were analysed. Results - Twenty- two patients were identified. In 15, genetic screening disclosed mutations / deletions in the SCN1A gene. Average time from seizure onset to diagnosis was 7.4 years. Mean age at seizure onset was 6.7 months, nine had hemiconvulsions and 13 had generalized tonicclonic seizures. The seizures were precipitated by fever in 17, by external heating in three. During second year of life, multiple seizure types and cognitive and motoric stagnation occurred. No patients became seizure- free with antiepileptic drugs. The effect of vagal nerve stimulation was disappointing. Conclusions - By making an early diagnosis, an extensive presurgical evaluation may be avoided, and the patient and their parents may be offered genetic guidance.
引用
收藏
页码:359 / 362
页数:4
相关论文
共 19 条
[1]   A long-term follow-up study of Dravet syndrome up to adulthood [J].
Akiyama, Mari ;
Kobayashi, Katsuhiro ;
Yoshinaga, Harumi ;
Ohtsuka, Yoko .
EPILEPSIA, 2010, 51 (06) :1043-1052
[2]   Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009 [J].
Berg, Anne T. ;
Berkovic, Samuel F. ;
Brodie, Martin J. ;
Buchhalter, Jeffrey ;
Cross, J. Helen ;
Boas, Walter van Emde ;
Engel, Jerome ;
French, Jacqueline ;
Glauser, Tracy A. ;
Mathern, Gary W. ;
Moshe, Solomon L. ;
Nordli, Douglas ;
Plouin, Perrine ;
Scheffer, Ingrid E. .
EPILEPSIA, 2010, 51 (04) :676-685
[3]   De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy:: a retrospective study [J].
Berkovic, Samuel F. ;
Harkin, Louise ;
McMahon, Jacinta M. ;
Pelekanos, James T. ;
Zuberi, Sameer M. ;
Wirrell, Elaine C. ;
Gill, Deepak S. ;
Iona, Xenia ;
Mulley, John C. ;
Scheffer, Ingrid E. .
LANCET NEUROLOGY, 2006, 5 (06) :488-492
[4]   Ketogenic diet in patients with Dravet syndrome [J].
Caraballo, RH ;
Cersósimo, RO ;
Sakr, D ;
Cresta, A ;
Escobal, N ;
Fejerman, N .
EPILEPSIA, 2005, 46 (09) :1539-1544
[5]   Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial [J].
Chiron, C ;
Marchand, MC ;
Tran, A ;
Rey, E ;
d'Athis, P ;
Vincent, J ;
Dulac, O ;
Pons, G .
LANCET, 2000, 356 (9242) :1638-1642
[6]   De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy [J].
Claes, L ;
Del-Favero, J ;
Ceulemans, B ;
Lagae, L ;
Van Broeckhoven, C ;
De Jonghe, P .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (06) :1327-1332
[7]  
Dravet C., 1978, VIEMED, V8, P543
[8]   Lamotrigine and seizure aggravation in severe myoclonic epilepsy [J].
Guerrini, R ;
Dravet, C ;
Genton, P ;
Belmonte, A ;
Kaminska, A ;
Dulac, O .
EPILEPSIA, 1998, 39 (05) :508-512
[9]   Topiramate in the treatment of highly refractory patients with Dravet syndrome [J].
Kroll-Seger, J. ;
Portilia, P. ;
Dulac, O. ;
Chiron, C. .
NEUROPEDIATRICS, 2006, 37 (06) :325-329
[10]  
Lambarri San Martin I, 1997, An Esp Pediatr, V46, P571